Nano-X Class Action Lawsuit Reminder for Investors
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: Globenewswire
- Lawsuit Timeline: Rosen Law Firm reminds investors who purchased Nano-X Imaging Ltd. (NASDAQ: NNOX) securities between March 31, 2025, and April 17, 2026, that they must apply to be lead plaintiff by August 11, 2026, to protect their rights in the class action.
- Fee Arrangement: Investors joining the Nano-X class action will incur no out-of-pocket costs, as the law firm operates on a contingency fee basis, which alleviates financial burdens and encourages broader participation from affected investors.
- Overview of Allegations: The lawsuit alleges that Nano-X made false statements regarding operational efficiency and product demand, resulting in significantly increased operating expenses and cash burn, which may necessitate substantial restructuring and impairment charges, thereby impacting the company's financial health.
- Law Firm Credentials: Rosen Law Firm is renowned for its successful track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company, demonstrating its strong capability and experience in protecting investor rights.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NNOX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NNOX
Wall Street analysts forecast NNOX stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.570
Low
7.00
Averages
7.00
High
7.00
Current: 1.570
Low
7.00
Averages
7.00
High
7.00
About NNOX
Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Nano X Imaging Reports Revenue Growth Amid Challenges
- Revenue Growth: Nano X Imaging Ltd reported revenue of $4.3 million, a 53.6% increase from $2.8 million in the comparable period, indicating initial market traction for its Nanox.ARC systems despite ongoing financial pressures.
- Margin Improvement: The gross profit margin for teleradiology services (GAAP) improved from 17% to 24%, reflecting progress in enhancing service efficiency and customer satisfaction, although the non-GAAP margin saw a slight decline.
- Cash Flow Concerns: As of March 31, 2026, cash and cash equivalents decreased to $44.2 million from $60 million as of December 31, 2025, raising concerns about the company's ability to continue operations in the near term.
- Strategic Restructuring: The company is undergoing a strategic restructuring to optimize its cost structure, expecting to lower burn rates by reducing headcount in Israel and optimizing operations in South Korea, aiming for improved capital efficiency in the future.
See More
Nano-X Class Action Lawsuit Reminder for Investors
- Lawsuit Timeline: Rosen Law Firm reminds investors who purchased Nano-X Imaging Ltd. (NASDAQ: NNOX) securities between March 31, 2025, and April 17, 2026, that they must apply to be lead plaintiff by August 11, 2026, to protect their rights in the class action.
- Fee Arrangement: Investors joining the Nano-X class action will incur no out-of-pocket costs, as the law firm operates on a contingency fee basis, which alleviates financial burdens and encourages broader participation from affected investors.
- Overview of Allegations: The lawsuit alleges that Nano-X made false statements regarding operational efficiency and product demand, resulting in significantly increased operating expenses and cash burn, which may necessitate substantial restructuring and impairment charges, thereby impacting the company's financial health.
- Law Firm Credentials: Rosen Law Firm is renowned for its successful track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company, demonstrating its strong capability and experience in protecting investor rights.
See More
Multiple Companies Face Class Action Lawsuits
- BitGo Lawsuit Overview: BitGo Holdings, Inc. (NYSE:BTGO) faces a class action lawsuit for the period from January 22, 2026, to May 13, 2026, alleging that the company failed to disclose the impact of declining digital asset prices on its financial performance, with a lead plaintiff deadline of August 7, 2026.
- Erasca Legal Issues: Erasca, Inc. (NASDAQ:ERAS) is involved in a class action lawsuit for the period from January 14, 2025, to April 26, 2026, due to undisclosed patent risks from improper comparisons, affecting investor confidence in the company's prospects, with a lead plaintiff deadline of August 10, 2026.
- Nano-X Lawsuit Details: Nano-X Imaging Ltd. (NASDAQ:NNOX) faces a class action lawsuit for the period from March 31, 2025, to April 17, 2026, alleging that the company overstated operational efficiency and product demand, leading to significant operational expenses and cash burn risks, with a lead plaintiff deadline of August 11, 2026.
- Microsoft Allegations: Microsoft Corporation (NASDAQ:MSFT) is involved in a class action lawsuit for the period from May 1, 2025, to January 28, 2026, for failing to disclose multiple issues with its Copilot product line, resulting in a decline in market share, with a lead plaintiff deadline of August 11, 2026.
See More
Class Action Filed Against Nano-X Imaging Ltd. for Securities Violations
- Class Action Initiated: Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Nano-X Imaging Ltd. aimed at recovering damages for investors who purchased securities between March 31, 2025, and April 17, 2026, highlighting significant misstatements regarding the company's operations and prospects during this period.
- Allegations of Misrepresentation: The complaint alleges that Nano-X's executives overstated operational efficiencies and product demand, while in reality, the company's production was misaligned with market needs, leading to significantly increased operating expenses and cash burn.
- Risk of Restructuring: Due to operational inefficiencies, Nano-X faces the risk of needing substantial restructuring and impairment charges, which could have profound implications for the company's financial health and increase the risk of investor losses.
- Investor Rights Protection: Affected investors have until August 11, 2026, to apply to be lead plaintiffs, with Bronstein, Gewirtz & Grossman, LLC offering legal support on a contingency fee basis to ensure the protection of investor rights.
See More
Class Action Filed Against Nano-X Imaging Ltd. Over Securities Violations
- Class Action Initiation: Pomerantz LLP has filed a class action lawsuit against Nano-X Imaging Ltd. in New Jersey on behalf of investors who purchased securities between March 31, 2025, and April 17, 2026, seeking damages for violations of federal securities laws, highlighting a significant trust crisis among investors regarding the company's management.
- Financial Loss Disclosure: On April 20, 2026, Nano-X reported a Q4 net loss of $33.4 million, including a $17.5 million impairment charge, indicating severe financial challenges during its restructuring process, which may further erode investor confidence.
- Executive Turnover Impact: The announcement of CFO Ran Daniel's resignation effective July 31, 2026, raises concerns about the company's leadership stability, potentially exacerbating market worries about its operational and financial health, which could negatively affect stock performance.
- Stock Price Volatility: Following the earnings report, Nano-X's stock price fell by $0.695, or 24.39%, closing at $2.155, reflecting a pessimistic market sentiment regarding the company's future prospects and possibly prompting further investor withdrawals.
See More
Nano-X Imaging Reports Q1 2026 Revenue Miss and Withdraws Outlook
- Revenue Shortfall: Nano-X Imaging reported Q1 2026 revenue of $4.3 million, missing consensus by $240,000, despite a year-over-year growth of approximately 54%, leading to a premarket stock drop of about 24% as investor expectations were not met.
- Widening Net Loss: The company's net loss widened by approximately 8% year-over-year to $14.3 million, primarily due to a $900,000 increase in operating expenses, even as its gross loss margin improved from 108% to 60%, indicating ongoing cost control challenges.
- Negative Cash Flow: The operational cash flow turned negative at $14.0 million in Q1, with cash and cash equivalents declining 26% year-over-year to $44.3 million, raising concerns about the company's ability to sustain operations for at least the next 12 months.
- Uncertain Outlook: Nano-X Imaging withdrew its full-year revenue outlook of $35 million, citing variability in system deployments and service executions that could impact revenue recognition timing, further intensifying market doubts about its going concern status.
See More
Nano X Imaging Reports Revenue Growth Amid Challenges
- Revenue Growth: Nano X Imaging Ltd reported revenue of $4.3 million, a 53.6% increase from $2.8 million in the comparable period, indicating initial market traction for its Nanox.ARC systems despite ongoing financial pressures.
- Margin Improvement: The gross profit margin for teleradiology services (GAAP) improved from 17% to 24%, reflecting progress in enhancing service efficiency and customer satisfaction, although the non-GAAP margin saw a slight decline.
- Cash Flow Concerns: As of March 31, 2026, cash and cash equivalents decreased to $44.2 million from $60 million as of December 31, 2025, raising concerns about the company's ability to continue operations in the near term.
- Strategic Restructuring: The company is undergoing a strategic restructuring to optimize its cost structure, expecting to lower burn rates by reducing headcount in Israel and optimizing operations in South Korea, aiming for improved capital efficiency in the future.
See More
Nano-X Class Action Lawsuit Reminder for Investors
- Lawsuit Timeline: Rosen Law Firm reminds investors who purchased Nano-X Imaging Ltd. (NASDAQ: NNOX) securities between March 31, 2025, and April 17, 2026, that they must apply to be lead plaintiff by August 11, 2026, to protect their rights in the class action.
- Fee Arrangement: Investors joining the Nano-X class action will incur no out-of-pocket costs, as the law firm operates on a contingency fee basis, which alleviates financial burdens and encourages broader participation from affected investors.
- Overview of Allegations: The lawsuit alleges that Nano-X made false statements regarding operational efficiency and product demand, resulting in significantly increased operating expenses and cash burn, which may necessitate substantial restructuring and impairment charges, thereby impacting the company's financial health.
- Law Firm Credentials: Rosen Law Firm is renowned for its successful track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company, demonstrating its strong capability and experience in protecting investor rights.
See More
Multiple Companies Face Class Action Lawsuits
- BitGo Lawsuit Overview: BitGo Holdings, Inc. (NYSE:BTGO) faces a class action lawsuit for the period from January 22, 2026, to May 13, 2026, alleging that the company failed to disclose the impact of declining digital asset prices on its financial performance, with a lead plaintiff deadline of August 7, 2026.
- Erasca Legal Issues: Erasca, Inc. (NASDAQ:ERAS) is involved in a class action lawsuit for the period from January 14, 2025, to April 26, 2026, due to undisclosed patent risks from improper comparisons, affecting investor confidence in the company's prospects, with a lead plaintiff deadline of August 10, 2026.
- Nano-X Lawsuit Details: Nano-X Imaging Ltd. (NASDAQ:NNOX) faces a class action lawsuit for the period from March 31, 2025, to April 17, 2026, alleging that the company overstated operational efficiency and product demand, leading to significant operational expenses and cash burn risks, with a lead plaintiff deadline of August 11, 2026.
- Microsoft Allegations: Microsoft Corporation (NASDAQ:MSFT) is involved in a class action lawsuit for the period from May 1, 2025, to January 28, 2026, for failing to disclose multiple issues with its Copilot product line, resulting in a decline in market share, with a lead plaintiff deadline of August 11, 2026.
See More
Class Action Filed Against Nano-X Imaging Ltd. for Securities Violations
- Class Action Initiated: Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Nano-X Imaging Ltd. aimed at recovering damages for investors who purchased securities between March 31, 2025, and April 17, 2026, highlighting significant misstatements regarding the company's operations and prospects during this period.
- Allegations of Misrepresentation: The complaint alleges that Nano-X's executives overstated operational efficiencies and product demand, while in reality, the company's production was misaligned with market needs, leading to significantly increased operating expenses and cash burn.
- Risk of Restructuring: Due to operational inefficiencies, Nano-X faces the risk of needing substantial restructuring and impairment charges, which could have profound implications for the company's financial health and increase the risk of investor losses.
- Investor Rights Protection: Affected investors have until August 11, 2026, to apply to be lead plaintiffs, with Bronstein, Gewirtz & Grossman, LLC offering legal support on a contingency fee basis to ensure the protection of investor rights.
See More
Class Action Filed Against Nano-X Imaging Ltd. Over Securities Violations
- Class Action Initiation: Pomerantz LLP has filed a class action lawsuit against Nano-X Imaging Ltd. in New Jersey on behalf of investors who purchased securities between March 31, 2025, and April 17, 2026, seeking damages for violations of federal securities laws, highlighting a significant trust crisis among investors regarding the company's management.
- Financial Loss Disclosure: On April 20, 2026, Nano-X reported a Q4 net loss of $33.4 million, including a $17.5 million impairment charge, indicating severe financial challenges during its restructuring process, which may further erode investor confidence.
- Executive Turnover Impact: The announcement of CFO Ran Daniel's resignation effective July 31, 2026, raises concerns about the company's leadership stability, potentially exacerbating market worries about its operational and financial health, which could negatively affect stock performance.
- Stock Price Volatility: Following the earnings report, Nano-X's stock price fell by $0.695, or 24.39%, closing at $2.155, reflecting a pessimistic market sentiment regarding the company's future prospects and possibly prompting further investor withdrawals.
See More
Nano-X Imaging Reports Q1 2026 Revenue Miss and Withdraws Outlook
- Revenue Shortfall: Nano-X Imaging reported Q1 2026 revenue of $4.3 million, missing consensus by $240,000, despite a year-over-year growth of approximately 54%, leading to a premarket stock drop of about 24% as investor expectations were not met.
- Widening Net Loss: The company's net loss widened by approximately 8% year-over-year to $14.3 million, primarily due to a $900,000 increase in operating expenses, even as its gross loss margin improved from 108% to 60%, indicating ongoing cost control challenges.
- Negative Cash Flow: The operational cash flow turned negative at $14.0 million in Q1, with cash and cash equivalents declining 26% year-over-year to $44.3 million, raising concerns about the company's ability to sustain operations for at least the next 12 months.
- Uncertain Outlook: Nano-X Imaging withdrew its full-year revenue outlook of $35 million, citing variability in system deployments and service executions that could impact revenue recognition timing, further intensifying market doubts about its going concern status.
See More
